RedHill Biopharma (RDHL) Asset Utilization Ratio (2013 - 2023)
RedHill Biopharma (RDHL) posted quarterly Asset Utilization Ratio of 0.76 for Q2 2023, up 69.8% year-over-year from 0.45 in Q2 2022, and up 58.52% quarter-over-quarter from 0.48 in Q1 2023.
RedHill Biopharma (RDHL) Asset Utilization Ratio (2013 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has reported Asset Utilization Ratio for 11 consecutive years, with 0.76 the latest figure, recorded in Q2 2023.
- In Q2 2023, Asset Utilization Ratio rose 69.8% year-over-year to 0.76; the TTM figure through Jun 2023 stood at 0.76 (up 69.8% YoY), while the FY2025 annual figure was 0.01, down 96.63% from the prior year.
- Asset Utilization Ratio climbed to 0.76 in Q2 2023 per RDHL's latest filing, from 0.48 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.76 in Q2 2023 and bottomed at 0.05 in Q1 2020.
- Historically, Asset Utilization Ratio has averaged 0.34 across 5 years, with a median of 0.39 in 2021.
- Annual changes were most pronounced in 2020 — Asset Utilization Ratio slumped 59.38% — and 2021, when it surged 712.54%.
- RedHill Biopharma's Asset Utilization Ratio stood at 0.11 in 2019, then surged by 234.97% to 0.37 in 2020, then increased by 26.61% to 0.47 in 2021, then slipped by 16.2% to 0.39 in 2022, then surged by 94.75% to 0.76 in 2023.
- Business Quant data shows RDHL's Asset Utilization Ratio at 0.76 in Q2 2023, 0.48 in Q1 2023, and 0.39 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 0.76 |
| Mar 31, 2023 | 0.48 |
| Dec 31, 2022 | 0.39 |
| Sep 30, 2022 | 0.44 |
| Jun 30, 2022 | 0.45 |
| Mar 31, 2022 | 0.45 |
| Dec 31, 2021 | 0.47 |
| Sep 30, 2021 | 0.44 |
| Jun 30, 2021 | 0.40 |
| Mar 31, 2021 | 0.42 |
| Dec 31, 2020 | 0.37 |
| Sep 30, 2020 | 0.27 |
| Jun 30, 2020 | 0.16 |
| Mar 31, 2020 | 0.05 |
| Dec 31, 2019 | 0.11 |
| Sep 30, 2019 | 0.13 |
| Jun 30, 2019 | 0.13 |
| Mar 31, 2019 | 0.13 |
| Dec 31, 2018 | 0.14 |
| Sep 30, 2018 | 0.20 |